← Back to All Filings

Director Buys $213K in Elanco Animal Health (ELAN) Stock

Low SignificanceDecember 16, 2025 at 5:05:15 PM EST

Elanco Animal Health Inc

$ELAN4CIK: 0001739104

Subscribe to track ELAN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Director Buys $213K in Elanco Animal Health (ELAN) Stock

Company: Elanco Animal Health Inc (ELAN) Form: 4 | Filed: 2025-12-16 Significance: Low

Insider: Kurzius Lawrence Erik Title: null | Relationship: Director

Transaction: • Type: Purchase • Shares: 10,000 • Price: $21.30 • Value: $213,000 • Owned After: 131,773

Key Insight: A director made a small open-market purchase, a routine transaction showing minor confidence but not materially significant given the company's size.

Market Context: The purchase represents a negligible 0.002% of Elanco's $10.48B market capitalization.

Comprehensive Analysis

SEC Filing Analysis: Elanco Animal Health Inc (ELAN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director made a routine open-market purchase of common stock.
  • Market Impact: The transaction is too small relative to the company's market capitalization to have a meaningful market impact.

Company Information

FieldValue
CompanyElanco Animal Health Inc
Ticker SymbolELAN
CIK0001739104
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameKurzius Lawrence Erik
CIK0001352090
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-12
Transaction CodeP (Open market or private purchase)
Security TypeCommon Stock
Shares Involved10,000
Price Per Share$21.30
Total Value$213,000
Shares Owned After131,773
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$213,000
% of Market Cap0.002%
Shares Transacted10,000
% of Shares OutstandingNot available
Post-Transaction Ownership131,773 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $10.48 billion, a $213,000 transaction is considered minor and routine.
  • Ownership Concentration: The purchase modestly increases the director's direct holdings but does not significantly alter the overall ownership structure.
  • Transaction Significance: The transaction value is well below the 0.1% of market cap threshold, indicating low material significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The size of the purchase is insignificant compared to the company's market capitalization and daily trading volume, making any price impact highly unlikely.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction is too small to affect trading volume.
  • Sentiment Indicator: Neutral. While an insider buy is technically a positive sign, its small scale prevents it from being a notable bullish signal.

Additional Context

Transaction Notes

  • This was a standard open-market purchase, indicating the director's decision to increase their stake at the current market price.
Topics:#SECFiling#InsiderTrading#ELAN#Form4#InsiderBuy#StockMarket#Investing#Elanco

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.